Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jan 11:7:3.
doi: 10.1186/1471-2202-7-3.

Carbenoxolone does not cross the blood brain barrier: an HPLC study

Yevgen Leshchenko  1 , Sergei Likhodii, Wendy Yue, William M Burnham, Jose L Perez Velazquez
Affiliations

Carbenoxolone does not cross the blood brain barrier: an HPLC study

Yevgen Leshchenko et al. BMC Neurosci. .

Abstract

Background: Carbenoxolone (CBX) is a widely used gap junctional blocker. Considering several reports indicating that transient gap junctional blockade could be a favourable intervention following injuries to central nervous tissue, and some current enthusiasm in studies using systemic injections of CBX, it is imperative to consider the penetration of CBX into central nervous tissue after systemic administrations. So far, only very indirect evidence suggests that CBX penetrates into the central nervous system after systemic administrations. We thus determined the amounts of CBX present in the blood and the cerebrospinal fluid of rats after intraperitoneal administration, using high performance liquid chromatography.

Results: CBX was found in the blood of the animals, up to 90 minutes post-injection. However, the cerebrospinal fluid concentration of CBX was negligible.

Conclusion: Thus, we conclude that, most likely, CBX does not penetrate the blood brain barrier and therefore recommend careful consideration in the manner of administration, when a central effect is desired.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Time course of CBX detected in the plasma after an i.p injection of 50 mg/Kg. Maximal plasma concentration (mean +/- SD) was found between 40-and 70 minutes post-injection.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Davidson JS, Baumgarten JM. Glycyrrhetinic acid derivatives: a novel class of inhibitors of gap junctional intercellular communication: Structure-activity relationship. J Pharm Exper Therapeutics. 1988;246:1104. - PubMed
    1. Sewell KJ, Shirly DG, Michael AE, Thompson A, Norgate DP, Unwin RJ. Inhibition of renal 11-beta-hydroxysteroid dehydrogenase in vivo by carbenoxolone in the rat and its relationship to sodium excretion. Clin Sci. 1998;95:435–443. doi: 10.1042/CS19980157. - DOI - PubMed
    1. Rozental R, Srinivas M, Spray DC. How to close a gap junction channel: Efficacies and potencies of uncoupling agents. Methods Mol Biol. 2001;154:447–476. - PubMed
    1. Bani-Yaghoub M, Underhill TM, Naus CCG. Gap junction blockage interferes with neuronal and astroglial differentiation ofmouse P19 embryonal carcinoma cells. Dev Genetics. 1999;24:69–81. doi: 10.1002/(SICI)1520-6408(1999)24:1/2<69::AID-DVG8>3.0.CO;2-M. - DOI - PubMed
    1. Frantseva MV, Kokarovtseva L, Naus CCG, Carlen PL, MacFabe D, Perez Velazquez JL. Specific gap junctions enhance the neuronal vulnerability to brain traumatic injury. J Neurosci. 2002;22:644–653. - PMC - PubMed

Publication types

LinkOut - more resources